The Nila Research Desk presents
Nila
Originals
Research-backed writing from the desk. Named sources, plain founder voice, no hedging.
CounterpointThe 228% isn't the story. Why it took this long is.
Manulife Canada reports hormone therapy claims among women 45 to 54 rose 228% between 2021 and 2025. That number is real, and it's being read on the wrong scale. A response from the Nila research desk.
Erin Beattie, founder of NilaSep 3, 20267 minRead original
Field noteYour ring does not know how last night felt
Wearables are everywhere in midlife health now. Here is what the validation research actually says about sleep tracking, where midlife women sit in that evidence, and the rules we set for ourselves before bringing Apple Health and Health Connect data into Nila.
Erin Beattie, founder of NilaAug 26, 20269 minRead original
Menopause care in Canada is stretched thin. Here’s where that leaves you and where we’ve decided to stand.
The president of the Society of Obstetricians and Gynecologists of Canada has publicly named the gap in menopause care. A national women’s health framework bill is moving through the Senate. In the years it’ll take to close the gap, this is what we’re seeing and the line we’re trying to hold.
Erin Beattie, founder of NilaJul 9, 202614 minRead original
The patient at the centre of the record doesn't exist
Most health data about menopause is built around a very specific woman: 51, cisgender, textbook timing. If you're not her, you're often invisible to the system. What the research actually says, what most apps miss, and what Nila is doing differently.
Erin Beattie, founder of NilaJul 5, 202612 minRead original